Zymeworks (ZYME) Earnings Date & Reports

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ZYME is expected to report earnings to fall 29.64% to -41 cents per share on July 30

Q2'26

Est.

$-0.42

Q1'26

Missed

by $0.16

Q4'25

Missed

by $0.07

Q3'25

Beat

by $0.20

Q2'25

Beat

by $0.48

The last earnings report on May 07 showed earnings per share of -58 cents, missing the estimate of -43 cents. With 699.01K shares outstanding, the current market capitalization sits at 1.70B.

View a ticker or compare two or three

Compare

ZYME

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ZYME